Muhieddine Makkouk is a seasoned life sciences executive with a distinguished track record of leading, transforming, and scaling organizations across the Middle East, Europe, the U.S., and emerging markets. Having lived and worked in 10 countries, he brings a uniquely global perspective and a deep ability to navigate complexity, drive growth, and build high-performing, multicultural teams.
He currently serves as Vice President & General Manager for Cepheid/Danaher's Diagnostics Platform in Saudi Arabia, where he is shaping the organization's strategic direction and accelerating business performance. Prior to Danaher, Muhieddine served as CEO of Medscience Healthcare and spent nearly a decade at Gilead Sciences in roles spanning regional leadership, alliance management, M&A integration, and country operations—consistently delivering transformation, commercial acceleration, and organizational alignment.
Earlier in his career, he held key leadership positions at Novartis, where he led major markets and regional clusters, drove double-digit growth, established new market access functions, and spearheaded large-scale organizational transformations.
Known for his integrity, clarity of thought, and people-first leadership style, Muhieddine excels at breaking silos, mobilizing teams around common goals, and creating cultures anchored in accountability, collaboration, and innovation.